As the world marshalled its resources in 2020 to fight the COVID-19 virus pandemic, major pharmaceutical companies were among those on the front lines, racing to develop, test and produce vaccines that could help protect billions of people. Technology played a key role in that effort, not only in creating new vaccines in record time but in ensuring they would be of the highest quality. Johnson & Johnson challenged its pharmaceutical arm, Janssen, with producing one billion doses of its vaccine. To reach that goal, Janssen turned to a contract manufacturer that specialized in rapid manufacturing of vaccines and other treatments in large quantities during public health emergencies.
TALLAHASSEE, FL – Advanced Manufacturing International (AMI) has been awarded a $2M grant